跳至主要内容
临床试验/JPRN-UMIN000042852
JPRN-UMIN000042852招募中4 期

Assessment of beneficial effects on sympathetic nerve activity by pemafibrate in hypertriglyceridemic patients with obesity and hypertension - Perseus study

Department of Cardiovascular Medicine, Kyoto University Hospital0 个研究点目标入组 30 人开始时间: 2021年1月5日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with contraindications to the target drug. 2. Patients with chronic atrial fibrillation or pacemaker implantation Patients with severe impairment of cardiovascular or pulmonary function such as shock, heart failure, myocardial infarction, pulmonary embolism, and other patients prone to hypoxemia. 4. Patients with excessive alcohol intake 5. Patients with severe infections, before and after surgery, or with severe trauma Patients with malnutrition, starvation, weakness, pituitary insufficiency, or adrenal insufficiency. 7. Other patients who are deemed inappropriate by the attending physician.

研究者

发起方
Department of Cardiovascular Medicine, Kyoto University Hospital

相似试验